The reactivatibility of cholinesterase inhibited by VX and sarin in man.
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation / Q000187:drug effects; D004912:Erythrocytes / Q000201:enzymology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D009934:Organization and Administration; D009946:Organothiophosphorus Compounds / Q000494:pharmacology*; D010091:Oximes / Q000494:pharmacology; D010465:Perception / Q000187:drug effects; D005082:Physical Exertion; D011437:Propylamines / Q000494:pharmacology; D011680:Pupil / Q000187:drug effects; D011726:Pyridinium Compounds / Q000494:pharmacology; D012524:Sarin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D012601:Scopolamine / Q000494:pharmacology; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D009946:Organothiophosphorus Compounds; D010091:Oximes; D011437:Propylamines; D011726:Pyridinium Compounds; D012524:Sarin; D012601:Scopolamine